UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 29, 2022

Accession Number:	0001213900-22-014845
Submission Type:	POS AM
CIK: 0001788028 Company Name: Jasper Therapeutics, Inc. File Number: 333-260306